BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14679334)

  • 21. [Cholestatic hepatitis by ticlopidin].
    García Ortega P; José Navarro J; Carvajal A; García del Pozo J
    Med Clin (Barc); 2001 Jan; 116(3):117. PubMed ID: 11181293
    [No Abstract]   [Full Text] [Related]  

  • 22. Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum.
    Tsai MH; Tsai SL; Chen TC; Liaw YF
    J Formos Med Assoc; 2000 Nov; 99(11):866-9. PubMed ID: 11155780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe ticlopidine-induced cholestatic syndrome.
    Mambelli E; Mancini E; Casanova S; Di Felice A; Santoro A
    Blood Purif; 2007; 25(5-6):441-5. PubMed ID: 18004066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible ticlopidine-induced cholestatic jaundice.
    Wengrower D
    Am Fam Physician; 2000 Sep; 62(6):1258, 1262. PubMed ID: 11011856
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ticlopidine-induced acute cholestatic hepatitis].
    Wegmann C; Münzenmaier R; Dormann AJ; Huchzermeyer H
    Dtsch Med Wochenschr; 1998 Feb; 123(6):146-50. PubMed ID: 9505953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ticlopidine-induced prolonged cholestasis: a case report.
    Amaro P; Nunes A; Maçôas F; Ministro P; Baranda J; Cipriano A; Martins I; Rosa A; Pimenta I; Donato A; Freitas D
    Eur J Gastroenterol Hepatol; 1999 Jun; 11(6):673-6. PubMed ID: 10418941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ticlopidine-induced hepatitis.
    Chen LK; Hsieh BH; Chen WC; Tsai ST; Hou MC
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):59-63. PubMed ID: 11310373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical evaluation of four cases of acute viral hepatitis complicated by pure red cell aplasia.
    Ide T; Sata M; Nouno R; Yamashita F; Nakano H; Tanikawa K
    Am J Gastroenterol; 1994 Feb; 89(2):257-62. PubMed ID: 8304314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ticlopidine-induced cholestasis].
    Meyer MI; Kuhn M; Bühler H; Bertschinger P
    Schweiz Med Wochenschr; 1999 Oct; 129(39):1405-9. PubMed ID: 10542998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed-onset ticlopidine-induced cholestatic jaundice.
    Kubin CJ; Sherman O; Hussain KB; Feinman L
    Pharmacotherapy; 1999 Aug; 19(8):1006-10. PubMed ID: 10453975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cholestatic hepatitis as a rare side effect of therapy with ticlopidine].
    Berent R; Hinterholzer G; Höbling W; Auer J; Haidenthaler A; Knoflach P
    Z Gastroenterol; 2000 Jul; 38(7):587-91. PubMed ID: 10965556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe cholestasis associated with ticlopidine.
    Grimm IS; Litynski JJ
    Am J Gastroenterol; 1994 Feb; 89(2):279-80. PubMed ID: 8304320
    [No Abstract]   [Full Text] [Related]  

  • 33. [A case of acute hepatitis A complicated with acute pure red cell aplasia].
    Tanri R; Nishimura H; Nakamura K; Ogasawara M; Akiyama K; Makino T; Tamura O
    Nihon Naika Gakkai Zasshi; 1990 Jul; 79(7):947-8. PubMed ID: 2121874
    [No Abstract]   [Full Text] [Related]  

  • 34. Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case-control study.
    Hirata K; Takagi H; Yamamoto M; Matsumoto T; Nishiya T; Mori K; Shimizu S; Masumoto H; Okutani Y
    Pharmacogenomics J; 2008 Feb; 8(1):29-33. PubMed ID: 17339877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ticlopidine (Ticlid) and severe bone marrow aplasia].
    Michon-Pasturel U; Rose C; Boulanger E; Pagniez D; Dequiedt P; Bauters F
    Rev Med Interne; 1996; 17(12):1041. PubMed ID: 9008756
    [No Abstract]   [Full Text] [Related]  

  • 36. Pure red cell aplasia and acute hepatitis during pregnancy.
    Ohno Y; Itakura A; Sano M; Mizutani S
    Gynecol Obstet Invest; 2002; 53(2):112-3. PubMed ID: 11961385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bone marrow aplasia related to ticlopidine].
    de Jaureguiberry JP; Galzin M; Talard P; Marlier S; Durupt S; Bouchiat C; Dussarat GV; Jaubert D
    Rev Med Interne; 1996; 17(12):1032-6. PubMed ID: 9008753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oxatomide-induced acute cholestatic hepatitis].
    Pauwels A; Debenes B; Zalcberg M; Levy VG
    Gastroenterol Clin Biol; 1992; 16(1):101-2. PubMed ID: 1347024
    [No Abstract]   [Full Text] [Related]  

  • 39. Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy.
    Tsui PT; Lai ST; Leung WS; Mok NS; Wu CW; Lau ST; Choi YC
    Hong Kong Med J; 2002 Feb; 8(1):57-9. PubMed ID: 11861996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Procainamide-induced pure red cell aplasia.
    Pasha SF; Pruthi RK
    Int J Cardiol; 2006 Jun; 110(1):125-6. PubMed ID: 16039734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.